Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

4275 ARTíCULOS , VIENDO DEL 4186 AL 4200

PUBMED

Genetic modifiers of Mendelian disease: Huntington's disease and the trinucleotide repeat disorders.

Holmans PA, Massey TH, Jones L.

Hum Mol Genet. 2017 Oct 1;26(R2):R83-R90. doi: 10.1093/hmg/ddx261.

0

0

0

PUBMED

Comparison of mHTT Antibodies in Huntington's Disease Mouse Models Reveal Specific Binding Profiles and Steady-State Ubiquitin Levels with Disease Development.

Bayram-Weston Z, Jones L, Dunnett SB, Brooks SP.

PLoS One. 2016 May 19;11(5):e0155834. doi: 10.1371/journal.pone.0155834.

0

0

0

PUBMED

Adenosine receptors and Huntington's disease.

Lee CF, Chern Y.

Int Rev Neurobiol. 2014;119:195-232. doi: 10.1016/B978-0-12-801022-8.00010-6. Review.

0

0

0

PUBMED

PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease.

Rosas HD, Doros G, Gevorkian S, Malarick K, Reuter M, Coutu JP, Triggs TD, Wilkens PJ, Matson W, Salat DH, Hersch SM.

Neurology. 2014 Mar 11;82(10):850-7. doi: 10.1212/WNL.0000000000000187.

0

0

0

PUBMED

Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.

Ribeiro M, Silva AC, Rodrigues J, Naia L, Rego AC.

Toxicol Sci. 2013 Dec;136(2):487-99. doi: 10.1093/toxsci/kft199.

0

0

0

PUBMED

Extrapyramidal syndrome with generalized chorea as an atypical presentation of progressive multifocal leukoencephalopathy.

Avellaneda-Gómez C, Torres Iglesias R, Puente Periz V, Güerri Fernández RC.

Neurologia. 2016 Mar 8. pii: S0213-4853(16)00033-5. doi: 10.1016/j.nrl.2016.01.001. [Epub ahead of print] English, Spanish. No abstract available.

0

0

0

PUBMED

Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model.

Lu Z, Marks E, Chen J, Moline J, Barrows L, Raisbeck M, Volitakis I, Cherny RA, Chopra V, Bush AI, Hersch S, Fox JH.

Neurobiol Dis. 2014 Nov;71:34-42. doi: 10.1016/j.nbd.2014.06.022.

0

0

0

PUBMED

Cognitive assessment strategies in Huntington's disease research.

Stout JC, Glikmann-Johnston Y, Andrews SC.

J Neurosci Methods. 2016 May 30;265:19-24. doi: 10.1016/j.jneumeth.2015.12.007. Review.

0

0

0

PUBMED

The direct medical costs of Huntington's disease by stage. A retrospective commercial and Medicaid claims data analysis.

Divino V, Dekoven M, Warner JH, Giuliano J, Anderson KE, Langbehn D, Lee WC.

J Med Econ. 2013 Aug;16(8):1043-50. doi: 10.3111/13696998.2013.818545.

0

0

0

PUBMED

Enhanced Store-Operated Calcium Entry Leads to Striatal Synaptic Loss in a Huntington's Disease Mouse Model.

Wu J, Ryskamp DA, Liang X, Egorova P, Zakharova O, Hung G, Bezprozvanny I.

J Neurosci. 2016 Jan 6;36(1):125-41. doi: 10.1523/JNEUROSCI.1038-15.2016.

0

0

0

PUBMED

Chorea, Hyperglycemia, Basal Ganglia Syndrome (C-H-BG) in an uncontrolled diabetic patient with normal glucose levels on presentation.

Bizet J, Cooper CJ, Quansah R, Rodriguez E, Teleb M, Hernandez GT.

Am J Case Rep. 2014 Apr 7;15:143-6. doi: 10.12659/AJCR.890179.

0

0

0

PUBMED

Persistent Sydenham's chorea is not associated with sustained lymphocyte dysfunction.

Torres KC, Rocha NP, Rezende VB, Dutra WO, Gollob KJ, Cardoso F, Teixeira AL.

Arq Neuropsiquiatr. 2016 Jan;74(1):5-9. doi: 10.1590/0004-282X20150179.

0

0

0

PUBMED

Huntington's Disease: An Immune Perspective.

Nayak A, Ansar R, Verma SK, Bonifati DM, Kishore U.

Neurol Res Int. 2011;2011:563784. doi: 10.1155/2011/563784.

0

0

0

PUBMED

Neuroleptic Malignant Syndrome Induced by Olanzapine in a Patient with Huntington's Disease.

Moreno JL, Palau Fayos JM, Díaz de Santiago A, García de Yébenes J.

J Huntingtons Dis. 2012;1(1):31-2. doi: 10.3233/JHD-2012-120008. No abstract available.

0

0

0

PUBMED

PINK1-induced mitophagy promotes neuroprotection in Huntington's disease.

Khalil B, El Fissi N, Aouane A, Cabirol-Pol MJ, Rival T, Liévens JC.

Cell Death Dis. 2015 Jan 22;6:e1617. doi: 10.1038/cddis.2014.581.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy